S212: A RANDOMIZED DOUBLE‐BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE‐2 OR HIGH RISK MYELOFIBROSIS.
- Resource Type
- Article
- Authors
- Zhang, Yi; Zhou, Hu; Zhuang, Junling; He, Aili; LI, Yarong; Yang, Linhua; Du, Xin; Gao, Sujun; He, Guangsheng; Hong, Mei; Jiang, Qian; Jiang, Zhongxing; Kai, Sun; Yue, Lingling; Zheng, Cuiping; Zhou, Zeping; Jin, Chenghao; Jing, Hongmei; Liu, Lin; Liu, Qingchi
- Source
- HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p
- Subject
- Language
- ISSN
- 25729241